As I indicated, in the budget, there is $2.5 billion—almost $3 billion—in investments flowing to the sector. I think the dedicated life sciences fund is really important. It's not a large amount of money. I think we need to make that happen, make it work, see the investments flow and then grow that. It should be bigger.
I think that's probably the biggest gap right now: venture capital. There is $60 billion in venture capital flowing to the biotech sector around the world. We need to actually access as much of that as possible to stay competitive, so anything we can do to get that I think would be really important.